| |
Pharmaceutical
and biopharmaceutical R&D represents the most important
research and technology-intensive industry in the Research
Triangle Region.
The region offers resources to support the complete
life cycle of pharmaceutical development, including:
- Quality university life sciences programs and corporate
research organizations that produce discoveries that
are transferred to emerging or existing companies,
resulting in new therapies or R&D tools.
- Local research universities, medical schools and
nonprofits that provide research services, as well
as preclinical and clinical trials, in support of
drug development efforts undertaken by companies ranging
in size from small to large.
- The Triangle’s contract research organizations
(CROs), which provide pharmaceutical research, testing,
development, preclinical trials, clinical trials and
associated services to ensure compliance with U.S.
Food and Drug Administration (FDA) regulations.
- Corporate and contract pharmaceutical and biomanufacturing
plants.
The Research
Triangle is one of very few places worldwide where such
a critical mass exists. North Carolina receives substantial
grant funds from the National Institutes of Health (NIH)
and, within North Carolina, the Triangle receives the
most NIH grants of any region. The public’s desire
for quality health care will continue to drive the search
for new discoveries, new drugs and advanced treatments.
Aging populations in most industrialized countries will
also favor growth of the pharmaceutical industry.
|
|
